Qiagen NV | QIA - 销售收入

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.11B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	销售	更改		日
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
argenx SE	USD 1.36B		240M	2026-06
Avita Medical	AUD 17.61M		805K	2025-12
Dianthus Therapeutics	USD 463K		179K	2026-03
Ionis Pharmaceuticals	USD 268M		22M	2026-06
IQVIA Holdings	USD 4.37B		220M	2026-06
Moderna	USD 100M		289M	2026-06
Organon & Co	USD 1.56B		100M	2026-06
Qiagen NV	USD 463.12M		43.9M	2026-06
Revvity	USD 729.68M		18.68M	2026-06
Tectonic Therapeutic	USD 0		0	2024-12
Viatris	USD 3.76B		240M	2026-06
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03